KALA BIO, Inc.
KALA
$5.28
$0.183.53%
NASDAQ
03/31/2025 | 12/31/2024 | ||||
---|---|---|---|---|---|
Revenue | -- | -- | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -- | -- | |||
Cost of Revenue | -- | -- | |||
Gross Profit | -- | -- | |||
SG&A Expenses | 9.33% | -4.52% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 12.57% | -1.14% | |||
Operating Income | -12.57% | 1.14% | |||
Income Before Tax | -9.44% | 8.66% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -9.44% | 8.66% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -9.44% | 8.66% | |||
EBIT | -12.57% | 1.14% | |||
EBITDA | -12.67% | 1.21% | |||
EPS Basic | 19.04% | 9.96% | |||
Normalized Basic EPS | 19.22% | 5.54% | |||
EPS Diluted | 19.04% | 9.96% | |||
Normalized Diluted EPS | 19.22% | 5.54% | |||
Average Basic Shares Outstanding | 35.17% | 1.45% | |||
Average Diluted Shares Outstanding | 35.17% | 1.45% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |